Drugs & Targets FDA approves Poherdy, first biosimilar to Perjeta, for breast cancer indication November 21, 2025Vol.51 No.43
Drugs & Targets FDA approves epcoritamab-bysp for follicular lymphoma indications November 21, 2025Vol.51 No.43
Drugs & Targets EC approves Libtayo as adjuvant treatment of high-risk cutaneous squamous cell carcinoma November 21, 2025Vol.51 No.43
Drugs & Targets GSK and LTZ collaborate to advance novel myeloid cell engagers in oncology November 21, 2025Vol.51 No.43
Drugs & Targets Freenome and Roche to expand collaboration to develop and commercialize cancer screening tests outside the U.S. November 21, 2025Vol.51 No.43
Drugs & Targets Microsoft and Qure.ai collaborate to accelerate AI lung cancer detection November 21, 2025Vol.51 No.43
